Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Gilead Offers Up $4.3bn For CymaBay And Phase III PBC Candidate
Feb 12 2024
•
By
Joseph Haas
Gilead adds in liver with CymaBay acquisition • Source: Shutterstock: Tada Images
More from Deals
More from Business